Larson J, Lieu T, Petchpradub V, LeDuc B, Ngo H, Rogers G A, Lynch G
Center for the Neurobiology of Learning and Memory, University of California, Irvine 92717-3800, USA.
J Neurosci. 1995 Dec;15(12):8023-30. doi: 10.1523/JNEUROSCI.15-12-08023.1995.
The effects of a benzoyl-piperidine drug (BDP) that facilitates AMPA receptor-mediated synaptic responses were tested on the acquisition and retention of long-term memory at dosages that had no detectable effects on a variety of performance measures. BDP-12 produced a dose-dependent suppression of exploratory activity in rats with statistically reliable effects occurring at 50 mg/kg (i.p.). The drug had no effects on balance beam performance at 30 mg/kg but at 45 mg/kg reduced the number of crossings made within a session; it did not, however, affect the time required to perform a traversal. The performance of well-trained rats presented with a familiar pair of odors (correct and incorrect) was not not detectably altered by BDP-12 at 30 mg/kg; however, the number of correct responses made in a five-trial test was reduced at 45 mg/kg. These results indicate that the AMPA receptor modulator at 30 mg/kg has little influence on arousal, motivation, sensori-motor processing, and attention; higher dosages cause a depression of learned and unlearned prepotent responses. The effects of the lower concentration were tested on two-odor discrimination learning in rats that had extensive training on the task. The animals (n = 20) were given three or five acquisition trials with novel odor pairs immediately after an injection of drug or vehicle and then tested 1-3 d later for retention in five unrewarded probe trials. Retention performance was not significantly better than chance 52.6 +/- 4.5% correct) for odors learned on vehicle injection days but was well above chance for odors learned on drug injection days (70.6 +/- 4.2% correct). Within-subject comparisons confirmed the memory enhancing effect of BDP-12 (p < 0.01). Analyses of performance during five training trials indicated that the rats made more correct responses on days on which they were given the drug than on days on which they were injected with vehicle (p < 0.02). Within-subject differences in acquisition were correlated with differences in retention (r = 0.70). There were no evident effects of the drug on response latencies during acquisition. These results suggest that AMPA receptor modulators reduce the amount of training needed for the formation of long-term memory and do so at dosages which have little effect on variables that secondarily influence acquisition. Possible reasons for this selectivity are discussed.
一种促进AMPA受体介导的突触反应的苯甲酰哌啶药物(BDP),在对各种行为指标无明显影响的剂量下,对长期记忆的获得和保持进行了测试。BDP - 12对大鼠的探究活动产生剂量依赖性抑制,在50 mg/kg(腹腔注射)时具有统计学上可靠的效应。该药物在30 mg/kg时对平衡木表现无影响,但在45 mg/kg时减少了一个训练时段内的穿越次数;然而,它并未影响完成一次穿越所需的时间。在面对一对熟悉气味(正确和错误)时,训练有素的大鼠在30 mg/kg剂量下,BDP - 12对其表现无明显改变;然而,在45 mg/kg时,五次试验测试中的正确反应次数减少。这些结果表明,30 mg/kg的AMPA受体调节剂对觉醒、动机、感觉运动处理和注意力影响很小;较高剂量会抑制习得和未习得的优势反应。在对该任务进行了广泛训练的大鼠中,测试了较低浓度对双气味辨别学习的影响。动物(n = 20)在注射药物或赋形剂后,立即对新的气味对进行三次或五次获得性试验,然后在1 - 3天后进行测试,在五次无奖励的探测试验中测试记忆保持情况。对于在注射赋形剂当天习得的气味,记忆保持表现并不显著优于随机水平(正确概率为52.6 +/- 4.5%),但对于在注射药物当天习得的气味,记忆保持表现远高于随机水平(正确概率为70.6 +/- 4.2%)。个体内比较证实了BDP - 12的记忆增强作用(p < 0.01)。对五次训练试验期间表现的分析表明,大鼠在给药当天比注射赋形剂当天做出了更多正确反应(p < 0.02)。个体内获得差异与记忆保持差异相关(r = 0.70)。在获得过程中,药物对反应潜伏期没有明显影响。这些结果表明,AMPA受体调节剂减少了形成长期记忆所需的训练量,并且在对次要影响获得的变量影响很小的剂量下就能做到这一点。讨论了这种选择性的可能原因。